STOCK TITAN

Avinger to Announce Fourth Quarter 2022 Results on March 15

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Avinger, Inc. (NASDAQ:AVGR), a medical device company based in Redwood City, CA, announced it will release its financial results for Q4 and full year 2022 on March 15, 2023, after market close. A conference call will follow at 1:30 PM PT/4:30 PM ET, accessible via telephone at +1-973-528-0011 with passcode 514070, and also via live webcast on the company's investor relations page. Avinger specializes in image-guided, catheter-based systems for diagnosing and treating Peripheral Artery Disease (PAD), estimated to impact over 12 million people in the U.S. and 200 million globally.

Positive
  • None.
Negative
  • None.

REDWOOD CITY, CA / ACCESSWIRE / March 2, 2023 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of vascular disease, today announced that it will release its financial results for the fourth quarter and full year 2022 after the close of trading on Wednesday, March 15, 2023. The Company will host a conference call beginning at 1:30 pm PT/4:30 pm ET.

To join the call by telephone, please dial +1-973-528-0011 and use passcode 514070. A live webcast of the conference call will be available online from the investor relations page of the Company's corporate website at www.avinger.com.

A replay of the webcast will be made available on Avinger's website, www.avinger.com, shortly after completion of the call.

About Avinger, Inc.
Avinger is a commercial-stage medical device company that designs and develops the first and only image-guided, catheter-based system for the diagnosis and treatment of patients with Peripheral Artery Disease (PAD). PAD is estimated to affect over 12 million people in the U.S. and over 200 million worldwide. Avinger is dedicated to radically changing the way vascular disease is treated through its Lumivascular platform, which currently consists of the Lightbox imaging console, the Ocelot and TigereyeTM family of chronic total occlusion (CTO) catheters, and the Pantheris® family of atherectomy devices. Avinger is based in Redwood City, California. For more information, please visit www.avinger.com.

Follow Avinger on Twitter and Facebook.

Investor Contact:
Matt Kreps
Darrow Associates Investor Relations
(214) 597-8200
mkreps@darrowir.com

SOURCE: Avinger, Inc.



View source version on accesswire.com:
https://www.accesswire.com/741591/Avinger-to-Announce-Fourth-Quarter-2022-Results-on-March-15

FAQ

When will Avinger announce its fourth quarter 2022 results?

Avinger will announce its fourth quarter 2022 results on March 15, 2023.

How can I access Avinger's conference call for financial results?

You can access Avinger's conference call by dialing +1-973-528-0011 and using passcode 514070.

What is Avinger known for?

Avinger is known for its intravascular, image-guided catheter-based systems designed for the diagnosis and treatment of vascular disease.

How many people are affected by Peripheral Artery Disease according to Avinger?

Avinger states that Peripheral Artery Disease affects over 12 million people in the U.S. and over 200 million worldwide.

Where can I find the live webcast of Avinger's conference call?

The live webcast of Avinger's conference call will be available on the investor relations page of their corporate website.

Avinger, Inc.

NASDAQ:AVGR

AVGR Rankings

AVGR Latest News

AVGR Stock Data

2.29M
2.93M
13.6%
2.84%
5.61%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States of America
REDWOOD CITY